Literature DB >> 19392903

Commercial potting soils as an alternative infection source of Legionella pneumophila and other Legionella species in Switzerland.

S Casati1, A Gioria-Martinoni, V Gaia.   

Abstract

Legionella spp. are pathogens that can cause Legionnaires' disease in humans through inhalation of contaminated aerosols. The principal reservoir for these microorganisms is water, but Legionella spp. have been isolated from composted vegetable and plant material, and from many potting mixes as well. In Australia, there have been several cases of Legionnaires' disease in which Legionella longbeachae has been isolated from potting soils. In Switzerland, the source of infection cannot always be identified as water or cooling towers: therefore, we have investigated 46 commercially available potting soils in Switzerland to determine the presence of Legionella spp. We were able to detect Legionella spp. in 45.7% (21/46) of the potting soil samples analysed by culture. Legionella pneumophila was present in 19.6% (9/46) of the samples and L. pneumophila serogroup 1 in 6.5% (3/46). Quantification by both culture and quantitative real-time PCR revealed high concentrations of legionellae in potting soils, ranging between 10(3) CFU/g and 10(5) CFU/g and 10(4) genomic units (GU)/g and 10(6) GU/g, respectively. Thus, potting soils may represent an alternative reservoir for Legionella spp. in Switzerland.

Entities:  

Mesh:

Year:  2009        PMID: 19392903     DOI: 10.1111/j.1469-0691.2009.02742.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  17 in total

1.  Reduction of Legionella spp. in water and in soil by a citrus plant extract vapor.

Authors:  Katie Laird; Elena Kurzbach; Jodie Score; Jyoti Tejpal; George Chi Tangyie; Carol Phillips
Journal:  Appl Environ Microbiol       Date:  2014-07-25       Impact factor: 4.792

Review 2.  Current and emerging Legionella diagnostics for laboratory and outbreak investigations.

Authors:  Jeffrey W Mercante; Jonas M Winchell
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

Review 3.  Septic arthritis due to Legionella cincinnatiensis: case report and review of the literature.

Authors:  Florian Banderet; Annette Blaich; Evelin Soleman; Valeria Gaia; Michael Osthoff
Journal:  Infection       Date:  2016-11-15       Impact factor: 3.553

4.  Detection of novel Chlamydiae and Legionellales from human nasal samples of healthy volunteers.

Authors:  Daniele Corsaro; Danielle Venditti
Journal:  Folia Microbiol (Praha)       Date:  2015-02-20       Impact factor: 2.099

5.  Caenorhabditis is a metazoan host for Legionella.

Authors:  Ann Karen C Brassinga; Jason M Kinchen; Meghan E Cupp; Shandra R Day; Paul S Hoffman; Costi D Sifri
Journal:  Cell Microbiol       Date:  2009-10-27       Impact factor: 3.715

6.  Comparative and functional genomics of legionella identified eukaryotic like proteins as key players in host-pathogen interactions.

Authors:  Laura Gomez-Valero; Christophe Rusniok; Christel Cazalet; Carmen Buchrieser
Journal:  Front Microbiol       Date:  2011-10-28       Impact factor: 5.640

7.  Legionella longbeachae and legionellosis.

Authors:  Harriet Whiley; Richard Bentham
Journal:  Emerg Infect Dis       Date:  2011-04       Impact factor: 6.883

8.  Results from the National Legionella Outbreak Detection Program, the Netherlands, 2002-2012.

Authors:  Jeroen W Den Boer; Sjoerd M Euser; Petra Brandsema; Linda Reijnen; Jacob P Bruin
Journal:  Emerg Infect Dis       Date:  2015-07       Impact factor: 6.883

9.  Detection limits of Legionella pneumophila in environmental samples after co-culture with Acanthamoeba polyphaga.

Authors:  Lisa Conza; Simona Casati; Valeria Gaia
Journal:  BMC Microbiol       Date:  2013-02-26       Impact factor: 3.605

10.  Presence of Legionella and free-living Amoebae in composts and bioaerosols from composting facilities.

Authors:  Lisa Conza; Simona Casati Pagani; Valeria Gaia
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.